Evidence map›Paper›PMID 41196993›Full record

ArticleScience (New York, N.Y.)2025

Adipogenin promotes the development of lipid droplets by binding a dodecameric seipin complex.

Chao Li, Xue-Nan Sun, Jan-Bernd Funcke, Lauri Vanharanta, Xavier Prasanna, Kaitlynn Gov, Yan Li, Megan Virostek, Chanmin Joung, Nolwenn Joffin and 28 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Sketching microprotein portraits.Protein science : a publication of the Protein Society · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Chao Li *Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-2060-4835
Xue-Nan Sun *Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-2588-6648
Jan-Bernd Funcke *Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-2596-3167
Lauri Vanharanta *Department of Anatomy and Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-7902-0009
Xavier PrasannaDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-2270-5493
Kaitlynn GovDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-1140-3932
Yan LiTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Megan VirostekTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0009-0005-4968-2529
Chanmin JoungTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-0004-3441
Nolwenn JoffinTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Kristiina KanervaDepartment of Anatomy and Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-1680-9448
Abel SzkalisityDepartment of Anatomy and Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-8388-5884
Waldemar KuligDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-7568-0029
Leon StraubTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0001-6738-0130
Shiuhwei ChenTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Joselin VelascoTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ayanna CobbTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Davide La PadulaTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0009-0001-9166-6152
May-Yun WangTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Toshiharu OnoderaTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-4439-0077
Csaba VörösDepartment of Anatomy and Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-6198-693X
Dae-Seok KimTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-5477-3952
Min KimTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Oleg VarlamovDivision of Metabolic Health and Disease, Oregon National Primate Research Center, Beaverton, OR, USA.ORCID 0000-0003-0294-215X
Yang LiDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0001-9601-4885
Chen LiuCenter for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-5922-0951
Andrea R NawrockiSpecialty Ophthalmology Discovery, Janssen R&D, Spring House, PA, USA.ORCID 0000-0003-1348-3999
Shangang ZhaoTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-9209-8206
Da Young OhTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-0687-6479
Zhao V WangDepartment of Diabetes and Cancer Metabolism, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.ORCID 0000-0002-9904-9538
Ruth GordilloTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0001-6533-2493
Joel M GoodmanDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
R Max WynnTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-1879-2136
W Mike HenneDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ilpo VattulainenDepartment of Physics, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-7408-3214
Yan HanDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-1207-7756
Elina IkonenDepartment of Anatomy and Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-8382-1135
Philipp E SchererTouchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0003-0680-3392

Funding

The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
Adiponectin, A Protein Secreted From Adipose TissueR01DK055758 · NIDDK · YESHIVA UNIVERSITY · PI SCHERER, PHILIPP E · 2000 to 2024
$10.9M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeffrey M Zigman · 2022 to 2026
$7.4M
White Adipose Tissue Physiology, Mitochondrial Function and AdiponectinR01DK099110 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PHILIPP E SCHERER · 2013 to 2026
$6.7M
Metabolic Benefits of Leptin ReductionR01DK127274 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI JOEL K. ELMQUIST, PHILIPP E SCHERER · 2021 to 2026
$5.1M
Physiological Role of Dedifferentiating Dermal Adipose TissueR01DK131537 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI SCHERER, PHILIPP E · 2022 to 2025
$2.1M
Modulation of Insulin Signaling in AdipocytesR01DK143576 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PHILIPP E SCHERER · 2025 to 2026
$1.6M
Regulation of GPCR-mediated intercellular communication in isletsR01DK136558 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI DAYOUNG OH · 2024 to 2026
$1.5M
NIA NIH HHS P01 AG051459NIDDK NIH HHS P30 DK127984NIDDK NIH HHS R01 DK055758NIDDK NIH HHS R01 DK099110NIDDK NIH HHS R01 DK127274NIDDK NIH HHS R01 DK131537NIDDK NIH HHS R01 DK136558NIDDK NIH HHS R01 DK143576
6 · The paper itself

Abstract

The microprotein adipogenin (Adig) is predominantly expressed in adipose tissues. Here, we found that Adig interacts with seipin to form a stable, rigid complex. We present the structure of the seipin-Adig complex at an overall resolution of ~3.0 angstroms. The structure revealed that mammalian seipin assembles into two distinct oligomeric forms: undecamers and dodecamers. Adig selectively bound to the dodecameric form and enhanced seipin assembly by bridging and stabilizing adjacent subunits. Functionally, this complex promoted lipid droplet development at both early and late stages. In transgenic mice, adipocyte-specific overexpression of Adig increased fat mass and enlarged lipid droplets, whereas Adig deletion disrupted triglyceride accumulation in brown adipose tissues. Thus, Adig can modulate lipid storage through its structural and functional interactions with seipin.

Indexed as

GTP-Binding Protein gamma SubunitsLipid DropletsNuclear ProteinsAdipocytesAdipose Tissue, BrownAnimalsCryoelectron MicroscopyHumansMiceMice, TransgenicProtein BindingProtein MultimerizationTriglyceridesBSCL2 protein, humanBscl2 protein, mouseGTP-Binding Protein gamma SubunitsNuclear ProteinsSMAF1 protein, mouseTriglycerides

Identifiers

PMID41196993
PMCPMC13231455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.